314 related articles for article (PubMed ID: 3189367)
1. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
Kantarjian HM; Shtalrid M; Kurzrock R; Blick M; Dalton WT; LeMaistre A; Stass SA; McCredie KB; Gutterman J; Freireich EJ
Am J Med; 1988 Nov; 85(5):639-44. PubMed ID: 3189367
[TBL] [Abstract][Full Text] [Related]
2. Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.
Cortes JE; Talpaz M; Beran M; O'Brien SM; Rios MB; Stass S; Kantarjian HM
Cancer; 1995 Jan; 75(2):464-70. PubMed ID: 7812917
[TBL] [Abstract][Full Text] [Related]
3. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique Hématologique.
Martiat P; Michaux JL; Rodhain J
Blood; 1991 Jul; 78(1):205-11. PubMed ID: 2070054
[TBL] [Abstract][Full Text] [Related]
4. RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia.
Hirsch-Ginsberg C; LeMaistre AC; Kantarjian H; Talpaz M; Cork A; Freireich EJ; Trujillo JM; Lee MS; Stass SA
Blood; 1990 Sep; 76(6):1214-9. PubMed ID: 2205309
[TBL] [Abstract][Full Text] [Related]
5. Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.
Shtalrid M; Talpaz M; Blick M; Romero P; Kantarjian H; Taylor K; Trujillo J; Schachner J; Gutterman JU; Kurzrock R
J Clin Oncol; 1988 Oct; 6(10):1569-75. PubMed ID: 3171624
[TBL] [Abstract][Full Text] [Related]
6. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.
Kurzrock R; Kantarjian HM; Shtalrid M; Gutterman JU; Talpaz M
Blood; 1990 Jan; 75(2):445-52. PubMed ID: 2403827
[TBL] [Abstract][Full Text] [Related]
7. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML.
van der Plas DC; Grosveld G; Hagemeijer A
Cancer Genet Cytogenet; 1991 Apr; 52(2):143-56. PubMed ID: 2021916
[TBL] [Abstract][Full Text] [Related]
8. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.
Nishigaki H; Misawa S; Inazawa J; Abe T
Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904
[TBL] [Abstract][Full Text] [Related]
9. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
Farhi DC; Luckey CN; Siddiqui AM
Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
[TBL] [Abstract][Full Text] [Related]
10. BCR rearrangement-negative chronic myelogenous leukemia revisited.
Kurzrock R; Bueso-Ramos CE; Kantarjian H; Freireich E; Tucker SL; Siciliano M; Pilat S; Talpaz M
J Clin Oncol; 2001 Jun; 19(11):2915-26. PubMed ID: 11387365
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
[TBL] [Abstract][Full Text] [Related]
12. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
Xue YQ
Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
[TBL] [Abstract][Full Text] [Related]
14. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
Melo JV; Myint H; Galton DA; Goldman JM
Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
[TBL] [Abstract][Full Text] [Related]
15. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
16. Philadelphia chromosome-negative chronic myeloid leukaemia: a report of 14 new cases.
Costello R; Lafage M; Toiron Y; Brunel V; Sainty D; Arnoulet C; Mozziconacci MJ; Bouabdallah R; Gastaut JA; Maraninchi D
Br J Haematol; 1995 Jun; 90(2):346-52. PubMed ID: 7794755
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia.
Cogswell PC; Morgan R; Dunn M; Neubauer A; Nelson P; Poland-Johnston NK; Sandberg AA; Liu E
Blood; 1989 Dec; 74(8):2629-33. PubMed ID: 2684296
[TBL] [Abstract][Full Text] [Related]
18. The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases.
Wiedemann LM; Karhi KK; Shivji MK; Rayter SI; Pegram SM; Dowden G; Bevan D; Will A; Galton DA; Chan LC
Blood; 1988 Feb; 71(2):349-55. PubMed ID: 3276362
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous features of Ph-negative CML--possible existence of Ph-negative, bcr-rearrangement-negative CML.
Kato Y; Sawada H; Tashima M; Yumoto Y; Okuda T; Ueda T; Yamagishi M; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1004-12. PubMed ID: 2588950
[TBL] [Abstract][Full Text] [Related]
20. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
